Engraftment of retroviral EGFP-transduced bone marrow in mice prevents rejection of EGFP-transgenic skin grafts
Open Access
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 8 (3) , 385-391
- https://doi.org/10.1016/s1525-0016(03)00210-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cellsBlood, 2001
- Green fluorescent protein-transgenic mice: immune functions and their application to studies of lymphocyte developmentImmunology Letters, 2000
- Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitopeGene Therapy, 2000
- Introduction of a Xenogeneic Gene via Hematopoietic Stem Cells Leads to Specific Tolerance in a Rhesus Monkey ModelMolecular Therapy, 2000
- Immune response to green fluorescent protein: implications for gene therapyGene Therapy, 1999
- THE GREEN FLUORESCENT PROTEINAnnual Review of Biochemistry, 1998
- ‘Green mice’ as a source of ubiquitous green cellsFEBS Letters, 1997
- Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cellsNature Biotechnology, 1996
- FACS-optimized mutants of the green fluorescent protein (GFP)Gene, 1996
- Green Fluorescent Protein as a Marker for Gene ExpressionScience, 1994